Platelets directed liposomes for the delivery of streptokinase: Development and characterization

European Journal of Pharmaceutical Sciences

Volumn 44, Issue 5, 2011, Pages 589-594

  Vaidya, Bhuvaneshwar ^a   Agrawal, G P ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Integrin receptors; Liposomes; Streptokinase; Thrombolytic agents

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CYANAMIDE; LIPOSOME; MACROGOL; STREPTOKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; CAROTID ARTERY; CHEMICAL BINDING; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; FILM; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYDRATION; LIPOSOMAL DELIVERY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CAROTID ARTERY THROMBOSIS; FIBRINOLYTIC AGENTS; LIPOSOMES; OLIGOPEPTIDES; PLATELET AGGREGATION; RATS; RATS, WISTAR; STREPTOKINASE; TISSUE DISTRIBUTION;

EID: 82155168275     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.10.004     Document Type: Article

References (34)

1. A. Alonso, C.E. Dempfle, A.D. Martina, M. Stroick, M. Fatar, K. Zohsel, E. Allémann, M.G. Hennerici, and S. Meairs In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound Thromb. Res. 124 2009 70 74
2. S.H. Baek, S.J. Park, S.E. Jin, J.K. Kim, C.K. Kim, and J.M. Hwang Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits Eur. J. Pharm. Biopharm. 72 2009 546 551
3. C. Bode, G. Meinhardt, M.S. Runge, M. Freitag, T. Nordt, M. Arens, J.B. Newell, W. Kübler, and E. Haber Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation Circulation 84 1991 805 813
4. T.W. Chung, S.S. Wang, and W.J. Tsai Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co- glycolide) (PLGA) nanoparticles Biomaterials 29 2 2008 228 237
5. L.T. Couto, J.L. Donato, and G. de Nucci Analysis of five streptokinase formulations using the euglobulin lysis test and the plasminogen activation assay Braz. J. Med. Biol. Res. 37 2004 1889 1894 (Pubitemid 40089942)
6. P. Dubey, V. Mishra, S. Jain, S. Mahor, and S.P. Vyas Liposomes modified with cyclic RGD peptide for tumor targeting J. Drug Target 12 5 2004 257 264 (Pubitemid 39294866)
7. T.A. Elbayoumi, and V.P. Torchilin Liposomes for targeted delivery of antithrombotic drugs Exp. Opin. Drug Deliv. 5 2008 1185 1198
8. S. Erdogan, A.Y. Özer Dr., B. Volkan, B. Caner, and H. Bilgili Thrombus localization by using streptokinase containing vesicular systems Drug Deliv. 13 2006 303 309 (Pubitemid 43739142)
9. W.P. Fay, N. Garg, and M. Sunkar Vascular functions of the plasminogen activation system Arterioscler. Thromb. Vasc. Biol. 27 2007 1231 1237 (Pubitemid 46809410)
10. E. Forssen, and W. Willis Ligand targeted liposomes Adv. Drug Deliv. Rev. 29 1998 249 271
11. A.S. Gupta, G. Huang, B.J. Lestini, S. Sagnella, K. Kottke-Marchant, and R.E. Marchant RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system Thromb. Haemost. 93 2005 106 114 (Pubitemid 40124263)
12. J.L. Heeremans, H.R. Gerritsen, S.P. Meusen, F.W. Mijnheer, R.S. Gangaram Panday, R. Prevost, C. Kluft, and D.J. Crommelin The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage J. Drug Target 3 1995 301 310 (Pubitemid 26032032)
13. J.L. Heeremans, R. Prevost, M.E. Bekkers, P. Los, J.J. Emeis, C. Kluft, and D.J. Crommelin Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA Thromb. Haemost. 73 1995 488 494
14. G. Huang, Z. Zhou, R. Srinivasan, M.S. Penn, K. Kottke-Marchant, R.E. Marchant, and A.S. Gupta Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets Biomaterials 29 2008 1676 1685
15. P. Juhlin, P.A. Bostrom, A. Torp, and A. Bredberg Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction J. Intern. Med. 245 1999 483 488 (Pubitemid 29232238)
16. I.-S. Kim, H.-G. Choi, H.-S. Choi, B.-K. Kim, and C.-K. Kim Prolonged Systemic Delivery of Streptokinase Using Liposome Arch. Pharm. Res. 21 1998 248 252 (Pubitemid 128661005)
17. J.Y. Kim, J.K. Kim, J.S. Park, Y. Byun, and C.K. Kim The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator Biomaterials 30 2009 5751 5756
18. A. Kunamneni, T.T.A. Abdelghani, and P. Ellaiah Streptokinase-the drug of choice for thrombolytic therapy J. Thromb. Thrombolysis 23 2007 9 23
19. K.D. Kurz, B.W. Main, and G.E. Sandusky Rat model of arterial thrombosis induced by ferric chloride Thromb. Res. 60 1990 269 280
20. H.F. Langer, and M. Gawaz Platelet-vessel wall interactions in atherosclerotic disease Thromb. Haemost. 99 2008 480 486 (Pubitemid 351549284)
21. J.K. Leach, E.A. O'Rear, E. Patterson, Y. Miao, and A.E. Johnson Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase Thromb. Haemost. 90 2003 64 70 (Pubitemid 36873860)
22. J.K. Leach, E. Patterson, and E.A. O'Rear Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators J. Thromb. Haemost. 2 2004 1548 1555 (Pubitemid 40186169)
23. B.J. Lestini, S.M. Sagnella, Z. Xu, M.S. Shive, N.J. Richter, J. Jayaseharan, A.J. Case, K. Kottke-Marchant, J.M. Anderson, and R.E. Marchant Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery J. Control. Rel. 78 2002 235 247 (Pubitemid 34081868)
24. H.R. Lijnen, B. van Hoef, V. Beelen, and D. Collen Characterization of the murine plasma fibrinolytic system Eur. J. Biochem. 224 1994 863 871 (Pubitemid 24288847)
25. R. Nallamothu, G.C. Wood, C.B. Pattillo, R.C. Scott, M.F. Kiani, B.M. Moore, and L.A. Thoma A Tumor Vasculature Targeted Liposome Delivery System for Combretastatin A4: Design, Characterization, and In vitro Evaluation AAPS PharmSciTech 7 2 2006 E1 E10
26. P.D. Nguyen, E.A. O'rear, A.E. Johnson, R. Lu, and B.M. Fung Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study Proc. Soc. Exp. Biol. Med. 192 1989 261 269 (Pubitemid 20051480)
27. P.D. Nguyen, E.A. O'rear, A.E. Johnson, E. Patterson, T.L. Whitsett, and R. Bhakta Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase Circ. Res. 66 1990 875 878 (Pubitemid 20086925)
28. I.Y. Sazonova, R.A. Mcnamee, A.K. Houng, S.M. King, L. Hedstrom, and G.L. Reed Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator J. Thromb. Haemost. 7 2009 1321 1328
29. H.D. Shah, and R.K. Goyal Glycoprotein IIb/IIIa receptor and its inhibition: a platelet-directed therapeutic strategy Ind. J. Pharmacol. 36 2004 133 139 (Pubitemid 38787064)
30. V.P. Torchilin Targeting of drugs and drug carriers within the cardiovascular system Adv. Drug. Deliv. Rev. 17 1995 75 101
31. S.P. Vyas, and B. Vaidya Targeted delivery of thrombolytic agents: role of integrin receptors Expert Opin. Drug Deliv. 6 2009 499 508
32. Y.Z. Xiang, L.Y. Kang, and X.M. Gao Strategies for antiplatelet targets and agents Thromb. Res. 123 2008 35 49
33. Y.S. Yim, J.-S. Choi, S.B. Jang, G.T. Kim, K. Park, C.H. Kim, J. Cheon, and D.G. Kim Pharmacokinetic properties and tissue storage of FITC conjugated SA-MnMEIO nanoparticles in mice Curr. Appl. Phys. 9 2009 e304 e307
34. N. Zhang, C. Chittasupho, C. Duangrat, T.J. Siahaan, and C. Berkland PLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1 Bioconjug Chem. 19 1 2008 145 152 (Pubitemid 351213845)